Feasibility of capturing radiation oncology quality metrics in a large integrated oncology practice.

Authors

null

Ajay Dubey

Texas Oncology, Dallas, TX

Ajay Dubey, Jeff Bernard, Jeffrey Limmer, Bret Heintz, Kyle Antes, Stacy Hartman, Bernard Taylor, Brennan Scott Cheek, Lalan S. Wilfong, John Russell Hoverman

Organizations

Texas Oncology, Dallas, TX, Texas Oncology, Fort Worth, TX, Texas Oncology, Longview, TX

Research Funding

Other

Background: Metrics to assess quality are important to improve processes of care. While such capture and reporting are common in medical oncology practices, it is less common with radiation oncology. As part of a large integrated oncology practice with more than 400 physicians and 57 radiation oncologists, we explored the feasibility of capturing and reporting a bundle of metrics at each of 52 radiation oncology practice sites. Methods: At the beginning of each quarter, the first 20 charts were sampled at each rad onc site of service to capture the following metrics: performance status at the start of radiation therapy, pain level at the start of XRT for patient with bone metastasis, cancer staging documented, dose limits to normal tissue tissues established and clearly documented for IMRT cases, and adherence to the 2015 US Oncology Breast Cancer XRT Pathways. Pathways adherence was captured via physician attestation. Beginning in the second quarter, Breast Cancer Pathways concordance with the final delivered plan was reported. Beginning in the 3rdquarter, additional pathways were captured (but not reported) for NSCLC, Prostate, Rectal Cancer, and Bone Metastasis sites. Results: See table. Conclusions: Availability of metrics data and compliance was greater than 80% in all 52 radiation oncology practice sites. Documentation of dose limits was seen as an opportunity for improvement via standardization of workflows, as there were multiple workflows within the record and verify system. Concordance rate between attestation of pathways compliance and the delivered plan was high. Breast cancer pathways compliance fell in the third quarter when additional pathways were added, suggesting that increasing complexity of metrics requirements may decrease performance.

Documentation
Compliance by Qtr
Performance status
at the start of
radiation therapy
Pain level at the
start of radiation
therapy for bone mets
Cancer stagingDose limits
to normal
tissues
Breast pathwayBreast Pathway
matches Final
Delivered Plan
Qtr 1 - Jan to Mar89%94%95%81%91%
Qtr 2 - Apr to Jun93%97%97%86%94%97%
Qtr 3 - Jul to Sep94%96%95%86%85%87%

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cost, Value, and Policy in Quality; Practice of Quality

Track

Cost, Value, and Policy in Quality,Practice of Quality

Sub Track

Learning from Projects Done in a Practice

Citation

J Clin Oncol 35, 2017 (suppl 8S; abstract 83)

DOI

10.1200/JCO.2017.35.8_suppl.83

Abstract #

83

Poster Bd #

C24

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Annual Meeting

The impact of end-of-life quality metrics on date of death and hospice documentation over time.

First Author: Divya Deepak

First Author: Tingyu WANG

First Author: Olajumoke Johnson